Sarilumab is prescribed for:
- Moderate-to-severe rheumatoid arthritis
- Patients who have failed DMARDs or biologics
- Immunology conditions
Subcutaneous alternative to tocilizumab.
Generic Name: Sarilumab
Brand Names: Kevzara
Sarilumab is an IL-6 receptor antagonist for moderate-to-severe rheumatoid arthritis.
Sarilumab is prescribed for:
Subcutaneous alternative to tocilizumab.
Common side effects:
Serious side effects:
Sarilumab is an IL-6 receptor antagonist similar to tocilizumab but given only subcutaneously.
Can be used as monotherapy (without methotrexate) more effectively than some TNF inhibitors.
Requires monitoring of neutrophils, platelets, and liver enzymes.
Learn more at MedlinePlus.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Sarilumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.